Background
==========

Herbs possess bioactive constituents such as polyphenolic compounds which regulate the defense system of the plant against oxidative insult. The most important bioactive constituents of plants are alkaloids, tannins, flavonoids, and phenolic compounds \[[@B1]\]. Plant polyphenols possess antioxidant, antimicrobial, anticancer, allelopathic and anti-inflammatory properties. *Launaea procumbens* (LP) is a plant used in the treatment of rheumatism, inflammation and oxidative dysfunction in the kidney \[[@B2]\], reproductive disorders \[[@B3]\], hormonal imbalances \[[@B4]\] and liver dysfunction \[[@B5]\]. Nutritional analyses have shown that *Launaea procumbens* is composed of synergic acid, 2-methyl-resercinol, salicylic acid, vanillic acid, and gallic acid \[[@B6]\]**,** which have antioxidant, anticancer, neuroprotective and cardioprotective effects \[[@B7]-[@B9]\]. Previous investigations have revealed that nutrient supplementation can significantly control cognitive and motor neuron dysfunction in old age \[[@B10]\]. Similarly, medicinal plants and their bioactive constituents can improve behavioral (motor and cognitive behavior), neuronal signaling and anti-inflammatory effects \[[@B11]\]. Supplementation with *Launaea procumbens* has been shown to inhibit the production of free radicals as well as to reduce lipid peroxidation in rats \[[@B2]\]. Cognitive functions are regulated by the central cholinergic system and the activity of the enzyme acetylcholinesterase. Alteration of acetylcholinesterase activity is the main indicator of Alzheimer's disease \[[@B12]-[@B14]\].

Therefore, the present study was designed to investigate the effect of administration of *Launaea procumbens* in rats on cognitive performance as well as the activity of acetylcholinesterase, and antioxidant enzymes in rat brain tissue homogenates.

Methods
=======

Collection of LP
----------------

Whole plant of *Launaea procumbens* at maturity was collected from District Bannu during Dec 2010, after identification the plant by Prof. Dr. Mir Azab Khan, Dean Faculty of Biological Sciences and submitted their voucher specimen at the Herbarium of Biotechnology, UST Bannu, KPK, Pakistan for future reference. After shade drying and chopping, plant was ground mechanically.

Plants extract preparation
--------------------------

1 kg dry powder of *Launaea procumbens* was socked in 4 liter aqueous methanol (80% methanol: 20% water) for 7 days. After one week of socking extract was filtrated using whatman filter 45. Filtrate was dried using rotary evaporator at 40 °C temperature and low pressure. The crude methanolic extract was stored at 4 ºC for *in vivo* investigations.

*In vitro* acetylcholinesterase inhibition assay
------------------------------------------------

Method of Ellman *et al.*\[[@B15]\] was used for assessment of AChE activity. Briefly, reaction mixture composed of 25 μl of ATCI (15mM), 75 μl of DTNB (3mM) and 50 μl of Tris- HCl, pH 8.0, (50mM), BSA (0.1%), and 25 μl of LPME was mixed and took OD at 405 nm after incubation for 5 min at room temperature. Inhibition of AChE was measured using blank in percentage. Experiments were repeated in triplicate.

Ethical approval of the study protocol
--------------------------------------

The study protocol was approved by an Ethics Committee of Quaid-i-Azam University for the proposed study as well as Feeding and Care of Laboratory Animals.

Animals
-------

30 rats (180--190 g, b.w.), were provided by NIH Islamabad, Pakistan. The entire rats were placed at 25±3ºC with a half day light and dark cycle. Food and water was supplied timingly. Rats were divided randomly into three groups as;

Group 1 (Control)

Group II 100 mg /kg b.w. LPME

Group III 200 mg /kg b.w. LPME

Experiment was conducted for 7 days. At the end of the experiment all animals were sacrificed; blood was drawn prior to the excision of brain, then treated with liquid nitrogen and stored at -80°C for further enzymatic analysis.

Behaviors study
---------------

Behaviors study (step-through passive avoidance task) was carried out using modified protocol as used by Kameyama et al. \[[@B16]\]. During this procedure, briefly after first training and acquisition test at 5th day rats were allowed into two chamber (light/dark) equipment with passive avoidance. At 5th day rats were allowed for the attainment test in the light compartment. After hundred seconds, animals were allowed to enter the dark chamber by opening door and recorded the latency with removing rats that reach after 100 seconds using electric shock. After 30 min the trial was repeated. Initial latency (IL) was recorded for entrance into the dark chamber. After 24 hours, rats were tested for step-through latency (measuring time into dark section) for 5 min. Experiment was repeated during 09:00am and 15:00pm.

Estimation of oxidative status
------------------------------

Homogenization of brain tissue was carried out in phosphate buffer (pH 7.6), centrifuged at 20,000rpm*×g* at 4°C for 2 hour, to obtain a soluble salt part (SS). Re-extraction of the pellets was carried out to get a soluble detergent part (DS) \[[@B17]\]. Supernatant of both parts were stored at −20°C. BSA was used for estimation of protein with different concentrations. Activities of various antioxidant enzymes are in brain tissue homogenate were measured as.

Catalase activity (CAT)
-----------------------

CAT activities were determined by the method of Chance and Maehly \[[@B18]\] with some modification. The reaction solution of CAT activities contained 2.5 ml of 50 mM phosphate buffer (pH 5.0), 0.4 ml of 5.9 mM H~2~O~2~ and 0.1 ml enzyme extract. Changes in absorbance of the reaction solution at 240 nm were determined after one minute. One unit of CAT activity was defined as an absorbance change of 0.01as units/min.

Super oxide dismutase assay (SOD)
---------------------------------

SOD activity was estimated by the method of Kakkar et al. \[[@B19]\]. Reaction mixture of this method contained 0.1 ml of phenazine methosulphate (186 μM), 1.2 ml of sodium pyrophosphate buffer (0.052 mM, pH 7.0), 0.3 ml of supernatant after centrifugation (1500 xg, 10 min followed by 10,000 × g, 15 min) of 10% homogenate was added to the reaction mixture. Enzyme reaction was initiated by adding 0.2 ml of NADH (780 μM) and stopped after 1 min by adding 1 ml of glacial acetic acid. Amount of chromogen formed was measured by recording color intensity at 560 nm. Results are expressed in units/mg protein.

Reduced glutathione assay (GSH)
-------------------------------

Reduced glutathione was estimated by the method of Jollow et al. \[[@B20]\]. 1.0 ml sample of 10% homogenate was precipitated with 1.0 ml of (4%) sulfosalicylic acid. The samples were kept at 4ºC for 1 hr and then centrifuged at 1200 × g for 20 min at 4ºC. The total volume of 3.0 ml assay mixture composed of 0.1 ml filtered aliquot, 2.7 ml phosphate buffer (0.1 M, pH 7.4) and 0.2 ml DTNB (5,5-dithiobis-2-nitrobenzoic acid), (100 mM). The yellow color of the mixture was developed, read immediately at 412 nm on a Smart SpecTM plus Spectrophotometer and expressed as μM GSH/g tissue.

Glutathione-*S*-transferase assay (GST)
---------------------------------------

Glutathione-*S*-transferase activity was assayed by the method of Habig et al. \[[@B21]\]. The reaction mixture consisted of 1.475 ml phosphate buffer (0.1 M, pH 6.5), 0.025 ml (CDNB) (1 mM), 0.2 ml reduced glutathione (1 mM), and 0.3 ml of 10% homogenate in a total volume of 2.0 ml. The changes in the absorbance were recorded at 340 nm and enzymes activity was calculated as nM CDNB conjugate formed/min/mg protein using a molar extinction coefficient of 9.6 × 10^3^/M cm.

Glutathione reductase assay (GSR)
---------------------------------

Glutathione reductase activity was determined by method of Carlberg and Mannervik \[[@B22]\]. The reaction solution composed of 1.65 ml phosphate buffer: (0.1 M, pH 7.6), 0.1 ml EDTA (0.5 mM), 0.1 ml NADPH (0.1 mM) 0.05 ml oxidized glutathione (1 mM), and 0.1 ml 10% homogenate in a total volume of 2 ml. Enzyme activity was quantitated at 25 ºC by measuring disappearance of NADPH at 340 nm and was calculated as nM NADPH oxidized/min/mg protein using molar extinction coefficient of 6.22 ×10^3^/M cm.

Glutathione peroxidase assay (GSH-Px)
-------------------------------------

Glutathione peroxidase activity was assayed by the method of Mohandas et al. \[[@B23]\]. The reaction mixture consisted of 1.49 ml phosphate buffer (0.1 M, pH 7.4), 0.1 ml sodium azide (1 mM), 0.05 ml glutathione reductase (1 IU/ml), 0.05 ml GSH (1 mM) 0.1 ml EDTA (1 mM), 0.1 ml NADPH (0.2 mM), 0.01 ml H~2~O~2~ (0.25 mM) and 0.1 ml 10% homogenate in a total volume of 2 ml. The disappearance of NADPH at 340 nm was recorded at 25ºC. Enzyme activity was calculated as nM NADPH oxidized/min/mg protein using molar extinction coefficient of 6.22 × 10^3^/M cm.

Estimation of lipid peroxidation assay (TBARS)
----------------------------------------------

The assay for lipid peroxidation was carried out following the method of Iqbal et al. \[[@B24]\]. The reaction mixture in a total volume of 1.0 ml contained 0.58 ml phosphate buffer (0.1 M, pH 7.4), 0.2 ml homogenate sample, 0.2 ml ascorbic acid (100 mM), and 0.02 ml ferric chloride (100 mM). The reaction mixture was incubated at 37ºC for 1 h in a shaking water bath. The reaction was stopped by addition of 1.0 ml 10% trichloroacetic acid. After addition of 1.0 ml 0.67% thiobarbituric acid, all the tubes were boiled in a water-bath for 20 min and then shifted to crushed ice-bath before centrifuging at 2500 × g for 10 min. The amount of TBARS formed in each of the samples was assessed by measuring optical density of the supernatant at 535 nm using spectrophotometer against a reagent blank. The results were expressed as nM TBARS/min/mg tissue at 37ºC using molar extinction coefficient of 1.56 × 10^5^/M cm.

*In Vivo* AChE assessment
-------------------------

AChE activity was determined using the colorimetric assay of Ellman et al. \[[@B17]\], as previously described. Briefly, in the 96 well plates, 25 μl of 15 mM ATCI, 75 μl of 3 DTNB and 75 μl of 50 mM Tris--HCl, pH 8.0, containing 0.1% BSA, were added and absorbance was read at 405 nm after five min incubation at room temperature. Any increase in absorbance due to the pontaneous hydrolysis of the substrate was corrected by subtracting the rate of the reaction before adding the enzyme. Then, 25 μl of sample (SS and DS fraction of brain homogenates) was added, and the absorbance was read again after 5 min ofincubation at room temperature. The AChE activity is expressed as mol/min/g of tissue protein. All determinations were carried out twice and in triplicate.

Statistical analysis
--------------------

Computer software SPSS 13.0 was used to determine the level of probability at LSD 0.05%.

Results
=======

Effect of LPME on AChE activity (*in vitro* study)
--------------------------------------------------

To access the *in vitro* efficiency of LPME in inhibiting AChE, different concentrations of LPME (5--150 μg/ml) were used: the results are presented in Figure [1](#F1){ref-type="fig"}. LPME exhibited moderate AChE inhibitory activity (48 μg/ml).

![**Effect of LPME on*in vitro*AChE activity**.](1472-6882-12-219-1){#F1}

Effect of LPME on the step-through test learning ability
--------------------------------------------------------

Behavioral changes in rats were measured with the administration of LPME (Table [1](#T1){ref-type="table"}). Significant changes were not observed during IL measurement in the control (28±3), 100 mg/kg b.w. LPME (24±3) and 200 mg/kg b.w. LPME (27±3) respectively. However, 200 mg/kg b.w. LPME markedly increased (*p* = 0.05) STL compared with the untreated control.

###### 

Effect of LPME on IL and STL

  **Treatment**         **IL**   **STL**
  --------------------- -------- ----------
  Control               28±3     101±32
  100 mg/kg b.w. LPME   24±3     108±50
  200 mg/kg b.w. LPME   28±7     218±50\*

The effect of orally administration of 100 mg/ kg b.w. and 100 mg/kg b.w. LPME extract on initial latency (IL) and step-through latency (STL) in the double trial step-through test. Asterisk (\*) indicates significant difference from the control littermates (*n* = 10/group).

Effect of LPME on body and tissue weight
----------------------------------------

Body weight of all rats were checked before experiment and after experiment, found non significant changes. Similarly no considerable differences (*p* \> 0.05) were found in tissue weight (whole brain) between non treated rats and LPME treated rats (Table [2](#T2){ref-type="table"}).

###### 

Showing body weight before and after treatment and wet brain weight

  **Treatment**                       **Control**   **100 mg/kg b.w. LPME**   **200 mg/kg b.w. LPME**
  ---------------------------------- ------------- ------------------------- -------------------------
  Body weight before treatment (g)     186.2±3.4           183.6±4.2                 188.2±7.9
  Body weight after treatment (g)      200.0±5.4           189.5±3.8                 195.8±7.2
  Wet brain weight (mg)                362.2±3.5           361.5±5.1                 357.1±3.4

Mean±S.E. values (*n* = 10/group). Control group received orally of saline.

Effect of LPME on brain AChE activity
-------------------------------------

Table [3](#T3){ref-type="table"} shows the activity of AChE in DS and SS homogenate of rats. Administration of 100 and 200 mg/kg b.w., considerably improved (*p* \< 0.05) AChE in DS and SS homogenate as comparatively to non treated rats. Remarkable inhibition (*p* \< 0.05) was found in the brain tissue of 200 mg/kg b.w., LPME (74% in DS and 71% in SS) comparative to 100 mg/kg b.w., LPME (42% in DS and 31% in SS) treated rats.

###### 

**Effect of LPME on*ex vivo*AChE activity (mol/min/g of tissue protein) in rat brain**

  **Treatment**          **Salt soluble (SS)-AChE**   **Detergent soluble (DS)-AChE**
  --------------------- ---------------------------- ---------------------------------
  Control                      0.175 ± 0.0057                  0.889 ± 0.074
  100 mg/kg b.w. LPME         0.101 ± 0.002\*                0.525 ± 0.031\*\*
  200 mg/kg b.w. LPME         0.74 ± 0.010\*\*               0.300 ± 0.051\*\*

a The AChE activity for each group denotes mean±S.E.M values.

\* *p* \< 0.05 significant difference from control.

\*\* *p* \< 0.01 significant difference from control.

Effect of LPME on brain oxidative status
----------------------------------------

Alteration in the activity of SOD, CAT, GSH, GSHpx, GST, GSR and TBARS are shown with administration of LPME in rats in a dose-dependent way (Table [4](#T4){ref-type="table"}). In particular, 200 mg/kg b.w., of LPME administration markedly *(p\<0.05)* reduced TBARS while considerably improved (*p* \< 0.05) activities of GSH, GST, GSR and GSHpx were significantly (*p* \< 0.05) in the cerebral tissue of rats to that of non treated control rats.

###### 

Effect of LPME on biochemical parameters of rat brain antioxidant status

  **Treatment**          **CAT (U/min)**   **SOD (U/mg protein)**   **GSHpx nmol/mg protein)**   **GSR (nmol/min/mg protein)**   **GST (nmol/min/mg protein)**   **GSH (μmol/g tissue)**   **TBARS (nmol/min/mg protein)**
  --------------------- ----------------- ------------------------ ---------------------------- ------------------------------- ------------------------------- ------------------------- ---------------------------------
  Control                   11.0±0.25             7.18±2.8                  43.3±3.58                     174.5±20.7                      115.8±26.11                   64.5±10.7                     184.5±8.7
  100 mg/kg b.w. LPME      15.5±2.8\*           13.5±1.4\*\*               55.3±1.85\*                  203.3±10.3\*\*                   139.8±13.3 \*                 88.0±8.3\*                    156.3±6.3\*
  200 mg/kg b.w. LPME      14.0±1.12\*         18.3±1.7 \*\*              65.3±5.14\*\*                 218.0±10.5 \*\*                 150.8±11.5\*\*                91.8±10.0\*\*                 144.0±5.5\*\*

a The rats brain biochemical parameters are expressed as mean±S.E.M values.

\* *p* \< 0.05 significant difference from control littermates (*n* = 10/group).

\*\* *p* \< 0.01 significant difference from control littermates (*n* = 10/group).

Discussion
==========

Medicinal plants and their bioactive fractions have significant roles in various disorders. These fractions have been shown to improve the learning behaviors and memories of experimental animals \[[@B16]\]. For determination of disorders of the central nervous system in experimental animals, a passive avoidance task (fear-aggravated test) is used for evaluation of learning and memory. In the present study, on the 5th day, rats were placed in a dark chamber to evaluate their vision and neuronal activity. The results of the present study revealed that the values of STL differed significantly, whereas no change was found in IL values. Similar findings were reported by Ellman *et al.*\[[@B15]\] in their study on *Vaccinium ashei* supplementation in mice. Our results suggested that administration of *Launaea procumbens* significantly improved memory and learning in experimental animals when using passive avoidance tests. Similar results have been reported in other experimental animals \[[@B16]\]. The data of the present study revealed that LPME administration in rats significantly decreased brain AChE activity. This phenomenon might be due to decreases in the transcription and translation of genes as well as enhanced cholinergic activity, which improves cognitive function \[[@B25]\]. AChE activity was reduced, with significant effects in rats treated with 200 mg/kg b.w. LPME compared with the untreated group. Oxidative stress and the antioxidant system have important roles in the pathophysiology of cerebral changes and brain disorders. Activities of superoxide dismutase (SOD) and catalase (CAT) are susceptible to oxidative changes. SOD and CAT have important roles in the defense against oxidative stress. They reduce hydrogen peroxide and prevent the generation of hydroxyl radicals, thereby shielding cellular constituents from oxidative damage. The present study revealed that administration of 100 mg/kg b.w. LPME and 200 mg/kg b.w. LPME increased the activity of SOD and CAT, as reported during supplementation of *Launaea procumbens* in rats \[[@B2]\]. GSH provides the first line of defense for the body by scavenging reactive oxygen species (ROS). The decreased concentration of GSH in the liver might be due to NADPH reduction or GSH utilization in the exclusion of peroxides \[[@B26]\]. GSH-dependent enzymes offer a second line of defense because they detoxify noxious byproducts generated by ROS and also help to avert the dissemination of free radicals \[[@B27]\]. GSH-Px detoxifies peroxides by reacting with GSH and converting it to GSSG, which is reduced to GSH by GSR \[[@B28]\]. GSHpx, glutathione reductase (GSR) and glutathione-S-transferase are basic antioxidant enzymes. Therefore, the profile of these enzymes and their alteration are a strong link with neurodegenerative diseases. Supplementation with *Launaea procumbens* for 7 days improved the activity of these basic antioxidant enzymes, showing protection against free radicals. From these results it was inferred that LPME administration in healthy rats significantly attenuated oxidative damage in the brain, increased the activity of antioxidant enzymes, increased GSH contents, increased the activity of AChE, and decreased the level of TBARS. These effects were related to enhancement in the passive avoidance tests. Despite these findings, further research on the mechanisms involved in this process is in progress.

Conclusion
==========

From the present result it is inferred that LPME is beneficial for improving the learning ability and antioxidant potential.
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